Mask side-effects are related to gender in long-term CPAP: results from the InterfaceVent real-life study.


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
06 Sep 2024
Historique:
received: 04 07 2024
accepted: 31 08 2024
medline: 7 9 2024
pubmed: 7 9 2024
entrez: 6 9 2024
Statut: epublish

Résumé

Over the past three decades, our understanding of sleep apnea in women has advanced, revealing disparities in pathophysiology, diagnosis, and treatment compared to men. However, no real-life study to date has explored the relationship between mask-related side effects (MRSEs) and gender in the context of long-term CPAP. The InterfaceVent-CPAP study is a prospective real-life cross-sectional study conducted in an apneic adult cohort undergoing at least 3 months of CPAP with unrestricted mask-access (34 different masks, no gender specific mask series). MRSE were assessed by the patient using visual analog scales (VAS). CPAP-non-adherence was defined as a mean CPAP-usage of less than 4 h per day. The primary objective of this ancillary study was to investigate the impact of gender on the prevalence of MRSEs reported by the patient. Secondary analyses assessed the impact of MRSEs on CPAP-usage and CPAP-non-adherence depending on the gender. A total of 1484 patients treated for a median duration of 4.4 years (IQ In real-life patients treated with long-term CPAP, there are gender differences in patient reported MRSEs. In the context of personalized medicine, these results suggest that the design of future masks should consider these gender differences if masks specifically for women are developed. However, only dry mouth, a side effect not related to mask design, impacts CPAP-usage and non-adherence. INTERFACEVENT IS REGISTERED WITH CLINICALTRIALS.GOV (NCT03013283).FIRST REGISTRATION DATE IS 2016-12-23.

Sections du résumé

BACKGROUND BACKGROUND
Over the past three decades, our understanding of sleep apnea in women has advanced, revealing disparities in pathophysiology, diagnosis, and treatment compared to men. However, no real-life study to date has explored the relationship between mask-related side effects (MRSEs) and gender in the context of long-term CPAP.
METHODS METHODS
The InterfaceVent-CPAP study is a prospective real-life cross-sectional study conducted in an apneic adult cohort undergoing at least 3 months of CPAP with unrestricted mask-access (34 different masks, no gender specific mask series). MRSE were assessed by the patient using visual analog scales (VAS). CPAP-non-adherence was defined as a mean CPAP-usage of less than 4 h per day. The primary objective of this ancillary study was to investigate the impact of gender on the prevalence of MRSEs reported by the patient. Secondary analyses assessed the impact of MRSEs on CPAP-usage and CPAP-non-adherence depending on the gender.
RESULTS RESULTS
A total of 1484 patients treated for a median duration of 4.4 years (IQ
CONCLUSION CONCLUSIONS
In real-life patients treated with long-term CPAP, there are gender differences in patient reported MRSEs. In the context of personalized medicine, these results suggest that the design of future masks should consider these gender differences if masks specifically for women are developed. However, only dry mouth, a side effect not related to mask design, impacts CPAP-usage and non-adherence.
TRIAL REGISTRATION BACKGROUND
INTERFACEVENT IS REGISTERED WITH CLINICALTRIALS.GOV (NCT03013283).FIRST REGISTRATION DATE IS 2016-12-23.

Identifiants

pubmed: 39243031
doi: 10.1186/s12931-024-02965-1
pii: 10.1186/s12931-024-02965-1
doi:

Banques de données

ClinicalTrials.gov
['NCT03013283']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

331

Informations de copyright

© 2024. The Author(s).

Références

Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687–98.
doi: 10.1016/S2213-2600(19)30198-5 pubmed: 31300334 pmcid: 7007763
Heinzer R, Marti-Soler H, Haba-Rubio J. Prevalence of sleep apnoea syndrome in the middle to old age general population. Lancet Respir Med. 2016;4:e5-6.
doi: 10.1016/S2213-2600(16)00006-0 pubmed: 26868630
Randerath W, Verbraecken J, de Raaff CAL, Hedner J, Herkenrath S, Hohenhorst W, et al. European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea. Eur Respir Rev. 2021;30: 210200.
doi: 10.1183/16000617.0200-2021 pubmed: 34853097 pmcid: 9489103
Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: an american academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2019;15:335–43.
doi: 10.5664/jcsm.7640 pubmed: 30736887 pmcid: 6374094
Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: an american academy of sleep medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2019;15:301–34.
doi: 10.5664/jcsm.7638 pubmed: 30736888 pmcid: 6374080
Yu J, Zhou Z, McEvoy RD, Anderson CS, Rodgers A, Perkovic V, et al. Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: a systematic review and meta-analysis. JAMA. 2017;318:156–66.
doi: 10.1001/jama.2017.7967 pubmed: 28697252 pmcid: 5541330
Weaver TE, Maislin G, Dinges DF, Bloxham T, George CFP, Greenberg H, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007;30:711–9.
doi: 10.1093/sleep/30.6.711 pubmed: 17580592 pmcid: 1978355
Gervès-Pinquié C, Bailly S, Goupil F, Pigeanne T, Launois S, Leclair-Visonneau L, et al. Positive airway pressure adherence, mortality, and cardiovascular events in patients with sleep apnea. Am J Respir Crit Care Med. 2022;206:1393–404.
doi: 10.1164/rccm.202202-0366OC pubmed: 35816570
Azarbarzin A, Zinchuk A, Wellman A, Labarca G, Vena D, Gell L, et al. Cardiovascular benefit of continuous positive airway pressure in adults with coronary artery disease and obstructive sleep apnea without excessive sleepiness. Am J Respir Crit Care Med. 2022;206:767–74.
doi: 10.1164/rccm.202111-2608OC pubmed: 35579605 pmcid: 9799106
Bublitz M, Adra N, Hijazi L, Shaib F, Attarian H, Bourjeily G. A narrative review of sex and gender differences in sleep disordered breathing: gaps and opportunities. Life. 2022;12:2003.
doi: 10.3390/life12122003 pubmed: 36556368 pmcid: 9786006
Martínez-García MÁ, Sierra-Párraga JM, Garcia-Ortega AA. Obstructive sleep apnea in women: we can do more and better. Sleep Med Rev. 2022;64: 101645.
doi: 10.1016/j.smrv.2022.101645 pubmed: 35640477
Patel SR, Bakker JP, Stitt CJ, Aloia MS, Nouraie SM. Age and sex disparities in adherence to CPAP. Chest. 2021;159:382–9.
doi: 10.1016/j.chest.2020.07.017 pubmed: 32687910
Bouloukaki I, Tsiligianni I, Schiza S. Evaluation of obstructive sleep apnea in female patients in primary care: time for improvement? Med Princ Pract. 2021;30:508–14.
doi: 10.1159/000518932 pubmed: 34438402 pmcid: 8740168
Martínez-García MÁ, Labarca G. Obstructive sleep apnea in women: scientific evidence is urgently needed. J Clin Sleep Med. 2022;18:1–2.
doi: 10.5664/jcsm.9684 pubmed: 34648424 pmcid: 8807894
Rotty M-C, Suehs CM, Mallet J-P, Martinez C, Borel J-C, Rabec C, et al. Mask side-effects in long-term CPAP-patients impact adherence and sleepiness: the InterfaceVent real-life study. Respir Res. 2021;22:17.
doi: 10.1186/s12931-021-01618-x pubmed: 33451313 pmcid: 7809735
Prigent A, Blanloeil C, Jaffuel D, Serandour AL, Barlet F, Gagnadoux F. Seasonal changes in positive airway pressure adherence. Front Med. 2024;11:1302431.
doi: 10.3389/fmed.2024.1302431
Solelhac G, Sánchez-de-la-Torre M, Blanchard M, Berger M, Hirotsu C, Imler T, et al. Pulse wave amplitude drops index: a biomarker of cardiovascular risk in obstructive sleep apnea. Am J Respir Crit Care Med. 2023;207:1620–32.
doi: 10.1164/rccm.202206-1223OC pubmed: 37017487 pmcid: 10273112
Prigent A, Blanloeil C, Serandour A-L, Barlet F, Gagnadoux F, Jaffuel D. A biphasic effect of age on CPAP adherence: a cross-sectional study of 26,343 patients. Respir Res. 2023;24:234.
doi: 10.1186/s12931-023-02543-x pubmed: 37759266 pmcid: 10537927
Bachour A, Vitikainen P, Virkkula P, Maasilta P. CPAP interface: satisfaction and side effects. Sleep Breath. 2013;17:667–72.
doi: 10.1007/s11325-012-0740-0 pubmed: 22763499
Borel JC, Tamisier R, Dias-Domingos S, Sapene M, Martin F, Stach B, et al. Type of mask may impact on continuous positive airway pressure adherence in apneic patients. PLoS ONE. 2013;8: e64382.
doi: 10.1371/journal.pone.0064382 pubmed: 23691209 pmcid: 3654912
Gagnadoux F, Le Vaillant M, Goupil F, Pigeanne T, Chollet S, Masson P, et al. Influence of marital status and employment status on long-term adherence with continuous positive airway pressure in sleep apnea patients. PLoS ONE. 2011;6: e22503.
doi: 10.1371/journal.pone.0022503 pubmed: 21857929 pmcid: 3157341
Laaka A, Hollmén M, Bachour A. Evaluation of CPAP mask performance during 3 years of mask usage: time for reconsideration of renewal policies? BMJ Open Respir Res. 2021;8: e001104.
doi: 10.1136/bmjresp-2021-001104 pubmed: 34799354 pmcid: 8606764
Zonato AI, Rosa CFA, Oliveira L, Bittencourt L. Comparing CPAP masks during initial titration for obstructive sleep apnea syndrome: 1 year experience. Braz J Otorhinolaryngol. 2022;88(Suppl 5):S63–8.
doi: 10.1016/j.bjorl.2021.10.007 pubmed: 34930686

Auteurs

Celia Vidal (C)

IDESP, INSERM, PreMEdical INRIA, CHU Montpellier, Montpellier University, Montpellier, France.
Groupe Adène, Montpellier, France.

Fanny Bertelli (F)

Groupe Adène, Montpellier, France.

Jean-Pierre Mallet (JP)

Groupe Adène, Montpellier, France.
Department of Respiratory Diseases, Arnaud de Villeneuve Hospital, CHRU Montpellier, Montpellier University Hospital, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France.
PhyMedExp (INSERM U 1046, CNRS UMR9214), Montpellier University, Montpellier, France.

Raphael Gilson (R)

Groupe Adène, Montpellier, France.

Jean-Christian Borel (JC)

Université Grenoble-Alpes, CHUGA Et INSERM U1300, Grenoble, France.

Frédéric Gagnadoux (F)

Departement of Respiratory and Sleep Medicine, University Hospital of Angers, Angers, France.

Arnaud Bourdin (A)

Groupe Adène, Montpellier, France.
Department of Respiratory Diseases, Arnaud de Villeneuve Hospital, CHRU Montpellier, Montpellier University Hospital, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France.
PhyMedExp (INSERM U 1046, CNRS UMR9214), Montpellier University, Montpellier, France.

Nicolas Molinari (N)

IDESP, INSERM, PreMEdical INRIA, CHU Montpellier, Montpellier University, Montpellier, France.
Groupe Adène, Montpellier, France.

Dany Jaffuel (D)

Groupe Adène, Montpellier, France. dany.jaffuel@wanadoo.fr.
Department of Respiratory Diseases, Arnaud de Villeneuve Hospital, CHRU Montpellier, Montpellier University Hospital, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France. dany.jaffuel@wanadoo.fr.
PhyMedExp (INSERM U 1046, CNRS UMR9214), Montpellier University, Montpellier, France. dany.jaffuel@wanadoo.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH